Jason Zhang

Jason is responsible for preclinical R&D, technology development, and pipeline strategy and execution. He has broad scientific knowledge in DAs including oncology, immunology, neurology, and infectious diseases, with modalities and MOAs covering small molecule, antibodies, ADCs, mRNA, AAV, and oligos. Jason is experienced in drug discovery and development with 7 drug candidates in phase I-III stages of clinical trials and contributed to one marketed drug. He has also engaged in business development and alliance management with academia, pharma, and biotech. Jason has a PhD in immunology from NYU with Dr. Dan Littman as advisor, a second PhD in chemistry from PUMC with Dr. Xiaotian Liang as advisor. Jason also conducted postdoc research at Yale and Harvard.